Shin Hyeong-Geol, Kim Woojun, Lee Jung Hwan, Lee Hyun-Soo, Nam Yoonho, Kim Jiwoong, Li Xu, van Zijl Peter C M, Calabresi Peter A, Lee Jongho, Jang Jinhee
Department of Radiology, School of Medicine, Johns Hopkins University, Baltimore, MD 21218, United States; F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD 21205, United States.
Department of Neurology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Neuroimage Clin. 2025;45:103748. doi: 10.1016/j.nicl.2025.103748. Epub 2025 Jan 30.
Susceptibility source-separation (χ-separation) MRI provides in-vivo proxy of myelin (diamagnetic susceptibility, χ) and iron concentrations (paramagnetic susceptibility, χ) in the central nervous system, potentially uncovering myelin- and iron-related pathology in multiple sclerosis (MS) lesions (e.g., demyelination, remyelination, and iron-laden microglia/macrophages formation). This study aims to monitor longitudinal changes in χ and χ signals within MS lesions using χ-separation and evaluate the association between lesional iron and remyelination capability.
Fifty participants with MS (pwMS) were followed annually over a mean period of 3.3 years (SD = 1.8 years) with MRI, including χ-separation, and clinical assessments. To monitor lesions from their early stage (lesion age < 1 year), we identified newly-noted lesions (NNLs) and contrast-enhancing lesions (CELs), and tracked their longitudinal changes in χ and χ signals.
Twenty-three pwMS were detected with NNLs and/or CELs (38 NNLs, 31 CELs;7 overlapped). Among these lesions (62 lesions in total), 27 exhibited χ hyperintensity, termed hyper-paramagnetic sign (HPS), indicating iron deposition "throughout" the lesion (not confined to rim sign). Early-stage HPS correlated with future remyelination failure detected by χ myelin signals (P < 0.001). After adjustment, lesions with early HPS demonstrated an annual loss in myelin signal (-1.94 ppb/year), whereas those without early HPS exhibited annual recovery (+0.66 ppb/year). Participants with confirmed disability improvement (CDI) had fewer HPS-positive lesions at baseline than those without CDI (P < 0.001).
The presence of HPS is associated with impaired remyelination capacity and a lack of disease improvement in pwMS. Identifying HPS may help demarcate lesions more amenable to myelin repair therapies.
敏感性源分离(χ分离)磁共振成像(MRI)可提供中枢神经系统中髓鞘(抗磁敏感性,χ)和铁浓度(顺磁敏感性,χ)的体内替代指标,有可能揭示多发性硬化症(MS)病变中与髓鞘和铁相关的病理情况(例如,脱髓鞘、再髓鞘化以及含铁小胶质细胞/巨噬细胞形成)。本研究旨在利用χ分离监测MS病变内χ和χ信号的纵向变化,并评估病变内铁与再髓鞘化能力之间的关联。
50例MS患者(pwMS)接受了平均为期3.3年(标准差=1.8年)的年度MRI随访,包括χ分离以及临床评估。为了从早期阶段(病变年龄<1年)监测病变,我们识别出新出现的病变(NNL)和强化病变(CEL),并追踪它们χ和χ信号的纵向变化。
23例pwMS检测到有NNL和/或CEL(38个NNL,31个CEL;7个重叠)。在这些病变(共62个病变)中,27个表现为χ高信号,称为超顺磁征(HPS),表明铁沉积“贯穿”病变(不限于边缘征)。早期HPS与χ髓鞘信号检测到的未来再髓鞘化失败相关(P<0.001)。调整后,有早期HPS的病变髓鞘信号每年下降(-1.94 ppb/年),而没有早期HPS的病变髓鞘信号每年恢复(+0.66 ppb/年)。确认有残疾改善(CDI)的参与者基线时HPS阳性病变比没有CDI的参与者少(P<0.001)。
HPS的存在与pwMS的再髓鞘化能力受损和疾病改善缺乏相关。识别HPS可能有助于区分更适合髓鞘修复治疗的病变。